Literature DB >> 21289159

ADAR2 editing enzyme is a novel human immunodeficiency virus-1 proviral factor.

Margherita Doria1, Sara Tomaselli2, Francesca Neri1, Silvia Anna Ciafrè3, Maria Giulia Farace3, Alessandro Michienzi3, Angela Gallo2.   

Abstract

The adenosine deaminases acting on RNA (ADAR) enzymes catalyse conversion of adenosine to inosine in dsRNA. A positive effect of ADAR1 on human immunodeficiency virus type 1 (HIV-1) replication has recently been reported. Here, we show that another ADAR enzyme, ADAR2, positively affects the replication process of HIV-1. We found that, analogously to ADAR1, ADAR2 enhances the release of progeny virions by an editing-dependent mechanism. However, differently from the ADAR1 enzyme, ADAR2 does not increase the infectious potential of the virus. Importantly, downregulation of ADAR2 in Jurkat cells significantly impairs viral replication. Therefore, ADAR2 shares some but not all proviral functions of ADAR1. These results suggest a novel role of ADAR2 as a viral regulator.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21289159     DOI: 10.1099/vir.0.028043-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  18 in total

Review 1.  Enhancement of replication of RNA viruses by ADAR1 via RNA editing and inhibition of RNA-activated protein kinase.

Authors:  Jean-François Gélinas; Guerline Clerzius; Eileen Shaw; Anne Gatignol
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

Review 2.  ADARs: viruses and innate immunity.

Authors:  Charles E Samuel
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

3.  Diverse selective regimes shape genetic diversity at ADAR genes and at their coding targets.

Authors:  Diego Forni; Alessandra Mozzi; Chiara Pontremoli; Jacopo Vertemara; Uberto Pozzoli; Mara Biasin; Nereo Bresolin; Mario Clerici; Rachele Cagliani; Manuela Sironi
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

4.  Restricting retrotransposons: ADAR1 is another guardian of the human genome.

Authors:  Elisa Orecchini; Loredana Frassinelli; Alessandro Michienzi
Journal:  RNA Biol       Date:  2017-07-21       Impact factor: 4.652

5.  Single-Strand Consensus Sequencing Reveals that HIV Type but not Subtype Significantly Impacts Viral Mutation Frequencies and Spectra.

Authors:  Jonathan M O Rawson; Daryl M Gohl; Sean R Landman; Megan E Roth; Morgan E Meissner; Tara S Peterson; James S Hodges; Kenneth B Beckman; Louis M Mansky
Journal:  J Mol Biol       Date:  2017-05-11       Impact factor: 5.469

6.  Variation of HIV-1 mutation spectra among cell types.

Authors:  Colleen M Holtz; Louis M Mansky
Journal:  J Virol       Date:  2013-02-28       Impact factor: 5.103

7.  ADAR2 Is Involved in Self and Nonself Recognition of Borna Disease Virus Genomic RNA in the Nucleus.

Authors:  Mako Yanai; Shohei Kojima; Madoka Sakai; Ryo Komorizono; Keizo Tomonaga; Akiko Makino
Journal:  J Virol       Date:  2020-02-28       Impact factor: 5.103

Review 8.  Protein kinase PKR and RNA adenosine deaminase ADAR1: new roles for old players as modulators of the interferon response.

Authors:  Christian K Pfaller; Zhiqun Li; Cyril X George; Charles E Samuel
Journal:  Curr Opin Immunol       Date:  2011-09-15       Impact factor: 7.486

9.  Testicular adenosine to inosine RNA editing in the mouse is mediated by ADARB1.

Authors:  Elizabeth M Snyder; Konstantin Licht; Robert E Braun
Journal:  Biol Reprod       Date:  2017-01-01       Impact factor: 4.285

Review 10.  Post-transcriptional regulation of LINE-1 retrotransposition by AID/APOBEC and ADAR deaminases.

Authors:  Elisa Orecchini; Loredana Frassinelli; Silvia Galardi; Silvia Anna Ciafrè; Alessandro Michienzi
Journal:  Chromosome Res       Date:  2018-02-02       Impact factor: 5.239

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.